Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P6JD
|
|||
| Former ID |
DIB015936
|
|||
| Drug Name |
RGN-259
|
|||
| Indication | Vaginal infection [ICD-11: GA02.0; ICD-10: N76.0] | Phase 2 | [1] | |
| Company |
Regenerx biopharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Actin (ACT) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Regulus Therapeutics. | |||
| REF 2 | Thymosin beta4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial. Cornea. 2015 May;34(5):491-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.